Target intelligence / Profile preview

MTCH1 pseudogene 2 (MTCH1P2)

Target: MTCH1P2
Molecular classification: Other (Pseudogene)

Overview

MTCH1 pseudogene 2 (MTCH1P2) is a pseudogene—an inactive DNA sequence that shares sequence similarity to the active mitochondrial carrier homolog 1 (MTCH1) gene. Unlike MTCH1, which encodes a mitochondrial outer membrane protein with roles in apoptosis and ferroptosis regulation[1][2][3][8], MTCH1P2 does not produce a functional protein and is not considered a drug target, nor does it have established biological or clinical relevance. Pseudogenes like MTCH1P2 may occasionally be transcribed, but lack coding potential and established roles in disease or as therapeutic targets[6].

Other names: MTCH1P2MTCH1 pseudogene 2

Mechanism of action

None

Biological functions

None (pseudogenes do not have known protein-coding biological function)

Disease associations

None established (pseudogene; no validated biological or disease function)

Beyond the preview

Go deeper on MTCH1 pseudogene 2 (MTCH1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTCH1 pseudogene 2 (MTCH1P2).

Explore the full profile